Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
BNIP3 is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. Additionally we are shipping BNIP3 Kits (10) and BNIP3 Proteins (5) and many more products for this protein.
Showing 10 out of 165 products:
Human Polyclonal BNIP3 Primary Antibody for IF, IHC (p) - ABIN388117
Kothari, Cizeau, McMillan-Ward, Israels, Bailes, Ens, Kirshenbaum, Gibson: BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. in Oncogene 2003
Show all 5 references for ABIN388117
Human Monoclonal BNIP3 Primary Antibody for ICC, IF - ABIN151087
Landes, Emorine, Courilleau, Rojo, Belenguer, Arnauné-Pelloquin: The BH3-only Bnip3 binds to the dynamin Opa1 to promote mitochondrial fragmentation and apoptosis by distinct mechanisms. in EMBO reports 2010
Show all 2 references for ABIN151087
Human Polyclonal BNIP3 Primary Antibody for EIA, IHC (p) - ABIN356828
Zhang, Heim, Meyhack: Novel BNIP1 variants and their interaction with BCL2 family members. in FEBS letters 1999
Show all 2 references for ABIN356828
Human Polyclonal BNIP3 Primary Antibody for ICC, IF - ABIN4284980
Yang, Yang, Guo, Williams, Weissler: PLAGL2 expression-induced lung epithelium damages at bronchiolar alveolar duct junction in emphysema: bNip3- and SP-C-associated cell death/injury activity. in American journal of physiology. Lung cellular and molecular physiology 2009
the results suggest that BNIP3 plays a vital role in regulating PINK1 (show PINK1 Antibodies) mitochondrial outer membrane localization, the proteolytic process of PINK1 (show PINK1 Antibodies) and PINK1 (show PINK1 Antibodies)/parkin (show PARK2 Antibodies)-mediated mitophagy under physiological conditions.
High BNIP3 expression is associated with chronic myelogenous leukemia.
Results suggest that changes in mitochondrial morphology and transmembrane potential, induced by mutant htt (show HTT Antibodies) protein, are dependent and linked to BNip3 and not to Bax (show BAX Antibodies)/Bak (show BAK1 Antibodies) activation.
Hypoxia-induced autophagy contributes to the invasion of salivary adenoid cystic carcinoma through the HIF-1alpha (show HIF1A Antibodies)/BNIP3 signaling pathway.
The data indicated that BNIP3 plays a vital role in the tumorigenesis of adenoid cystic carcinoma and could be a new target for gene therapy of adenoid cystic carcinoma.
BNIP3 deletion can be used as a prognostic (show HIF1A Antibodies)marker of tumor progression to metastasis in human triple-negative breast cancer
BNIP3 expression was found to be regulated by Sp3 (show SP3 Antibodies) in prostate cancer.
phosphorylation of these C-terminal BNIP3 residues blocks cell death without preventing autophagy, providing evidence that the two functional roles of BNIP3 can be regulated independently
Bnip3 dual-functionality and crosstalk between mitophagy and apoptosis pathways is presented here.
these findings revealed that silibinin induced autophagic cell death through ROS (show ROS1 Antibodies)-dependent mitochondrial dysfunction and ATP depletion involving BNIP3 in MCF7 cells.
Down-regulation of Bcl2/adenovirus E1B 19-kDa-interacting protein 3 (BNIP3) by olomoucine, a cyclin (show PCNA Antibodies)-dependent kinasesinhibitor, reduces lipopolysaccharide - and nitric oxide-induced cell death in BV2 (show DNAH9 Antibodies) microglial cells. Olomoucine may protect cells by limiting proinflammatory responses, thereby reducing nitric oxide generation.
data outline Bnip3 as a key effector of PPARgamma (show PPARG Antibodies)-mediated adipose mitochondrial network fragmentation, improving insulin (show INS Antibodies) sensitivity and limiting oxidative stress.
BNIP3 interacts with the mitochondrial outer membrane directly via mitochondrial BAX (show BAX Antibodies).
Data show that TGFbeta (show TGFB1 Antibodies)-activated kinase-1 (TAK1 (show NR2C2 Antibodies)) activated nuclear factor of activated T-cells (NFAT (show NFATC1 Antibodies))/NF-kappa B (NFkappaB (show NFKB1 Antibodies)), downregulated BCL2-adenovirus E1B interacting protein 3 (Bnip3), and inhibited cardiac cell death.
propose that BNIP3 acts as a brake on HIF-1 (show HIF1A Antibodies) activity serving to increase rates of mitophagy in response to hypoxia and to limit production of damaging ROS (show ROS1 Antibodies) that would further amplify HIF-1 (show HIF1A Antibodies) expression and promote tumor progression to metastasis
Results suggest that Bnip3 regulates cardiac gene expression and perhaps myocyte morphology by activating nuclear p300 acetyltransferase and hyperacetylating histones and its selective transcription factors.
regulates mitophagy during hypoxia, whereas NIX (show BNIP3L Antibodies) is required for mitophagy during development of the erythroid lineage.
BNIP3 primarily regulates basal level of mitophagy in physiological conditions, whereas BNIP3 exclusively activates excessive mitophagy leading to cell death.
This gene is a member of the BCL2/adenovirus E1B 19 kd-interacting protein (BNIP) family. It interacts with the E1B 19 kDa protein, which protects cells from virally-induced cell death. The encoded protein also interacts with E1B 19 kDa-like sequences of BCL2, another apoptotic protector. This protein contains a BH3 domain and a transmembrane domain, which have been associated with pro-apoptotic function. The dimeric mitochondrial protein encoded by this gene is known to induce apoptosis, even in the presence of BCL2.
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3
, BCL2/adenovirus E1B 19kD-interacting protein 3
, BCL2/adenovirus E1B 19 kDa-interacting protein 1, NIP3
, BCL2/adenovirus E1B 19kDa-interacting protein 1, NIP3
, BCL2/adenovirus E1B interacting protein 1, NIP3
, BCL2/adenovirus E1B 19 kDa-interacting protein 3